The cost estimation of severe exacerbations is important as it could trigger further research and also provide the opportunity of creating national epidemiological and economic data. Such data could contribute to the estimation of the total economic and societal burden of COPD in the country.
Aim of the studyThe aim of this study was to examine the relationship between religiosity, mental health, and psychological resilience in breast cancer patients.Material and methodsA cross-sectional study was conducted in an oncology department of a hospital in northern Greece during February and March 2017. The sample consisted of 152 breast cancer patients. Data were collected with the following instruments: Patient Health Questionnaire two-item scale, Generalised Anxiety Disorder two-item scale, Connor-Davidson Resilience Scale 25, and Centrality of Religiosity Scale. Also, patients’ characteristics were included, specifically demographic, social, and clinical information. Statistical analyses were conducted with the Statistical Package for the Social Sciences V25.ResultsAccording to our results, approximately 1 out of 3 patients had depression and anxiety. Also, the sample had moderate resilience and were moderately religious. Patients who were classified as end-stage cancer patients and those who underwent mastectomy found to be more religious. Religiosity correlated positively with the resilience, while no correlation was found with depression, anxiety, and symptom burden. Based on regression results, religious beliefs seem to be a predictive factor for resilience and resilience is a predictive factor for depression.ConclusionsOur findings show that there was no association between religiosity and mental health, while a strong relation was highlighted between religious beliefs and psychological resilience. This study should constitute a starting point for further assessments regarding the fact that religiosity can provide social support that facilitates psychological adaption to illness and helps cancer patients to cope with their illness, which should be recognised by health care professionals.
Even though tiotropium is more expensive to buy than salmeterol in the Greek NHS (using Greek costs there was no statistically significant difference in total costs between tiotropium and salmeterol), overall, during the course of a year, it is actually associated with a lower prevalence of exacerbations and lower treatment costs and thus may represent a viable and cost-effective alternative in the Greek NHS setting.
ObJEctIVE: to estimate the impact of hypoglycemia on the Quality of Life (QoL) and its prevalence in patients with type 2 diabetes mellitus (t2DM) in Greece. DEsIGN: A crosssectional epidemiological study was conducted in 6631 patients with t2DM. QoL was assessed with the patient self-administered ADDQoL-19. reliability analysis of patients' outcomes was performed to assess internal consistency of the ADDQoL-19. Patients were categorized according to hypoglycemia experience and diabetes control. controlled patients were considered as having Hb1Ac <7% (53mmol/mol) and hypoglycemic episodes were defined as laboratoryconfirmed clinical symptomatic events. rEsULts: In total, 59% of the sample had HbA1c >7% (53mmol/mol) and 20.4% of patients had a history of laboratory-confirmed hypoglycemia. the mean age was 60 years and the mean t2DM duration was 10 years. the mean QoL score was -3.09±1.9 for the total sample and the mean score of non-hypoglycemic patients was -3.05±2, while the respective score of hypoglycemic patients was -3.26 ±1.8, (p≤0.001). similar results were observed in the group of controlled and uncontrolled patients, who scored -2.73±1.7 and -3.33±1.9, respectively (p≤0.001). comparable results were identified in the majority of the ADDQoL-19 instrument dimensions. cONcLUsIONs: the QoL of t2DM patients is affected significantly by hypoglycemia and the level of disease control. In diabetes treatment, the ultimate goal should be optimal glycemic control without debilitating hypoglycemic episodes which compromise patients' QoL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.